Algo version: 0.98b
TATA Health International is listed at the HKSE Exchange
TATA Health International [1255.HK]
HKSE Sector: Consumer Cyclical Industry:Apparel Footwear Accessories

Is TATA Health International stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, TATA Health International pays dividends. Last time was Monday 8th of June 2015 where the investors holding the stock on Wednesday 18th of March 2015 were paid HKD0.023 per share. Over the last 2 times between 2014 and 2015, TATA Health International has paid HKD0.063 with an average of HKD0.03 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for TATA Health International 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was HKD5.55, you would have made a loss of HKD-5.25 per share or -94.59%

We do not have enough data to give you this answer.

TATA Health International has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.42, the company's ability to pay off the debt is normal. TATA Health International has a good net profit margin of 6.65% and should have high tolerances against inflation.

We have calculated the inflation risk for TATA Health International to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.